The shares of large drugmakers like Lilly, Gilead and J&J keep hitting record highs Eli Lilly’s stock hit another record high this week after reporting its third-quarter results. It markets Mounjaro, a GLP-1 medication for people with Type 2 diabetes, which is the world’s top-selling drug. Who would have believed that the boring healthcare industry would be the hottest stock sector of 2026? have long been known for producing steady results, driven by patient demand and government reimbursement.
Copyright ©2026 MarketWatch, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8 After Intel’s historic stock drop, analysts say there’s no reason to buy the dip Stop planning your retirement around this, says the chief wealth officer at WSFS Bank Trump administration is illegally delaying student-debt forgiveness for tens of thousands of public servants, lawsuit alleges Private equity in your 401(k)? Heed Warren Buffett’s warning.
Jaimy Lee is a healthcare editor and reporter for MarketWatch. She is based in New York. Intraday Data provided by FACTSET and subject to terms of use.
Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only.
Intraday data delayed at least 15 minutes or per exchange requirements.
Extract — continue reading at the source.
